According to Entrada Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.58. In 2022 the company made an earnings per share (EPS) of -$3.02 a decrease over its 2021 EPS that were of -$2.29.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.58 | -14.57% |
2022 | -$3.02 | 31.74% |
2021 | -$2.29 |